OBJECTIVES: To evaluate the influence of an aortic root abscess on perioperative outcomes and long-term survival in patients with active infectious endocarditis that was treated surgically. METHODS: From 1996 to 2017, 336 consecutive patients were treated with aortic valve or root replacement for infective endocarditis, including patients with (n = 179) or without (n = 157) a root abscess. Data were obtained from the Society of Thoracic Surgeons data warehouse, through chart review, patient surveys, and National Death Index data. RESULTS: Demographic characteristics were similar between groups except the root abscess group had a significantly lower prevalence of congestive heart failure and higher rates of prosthetic valve endocarditis. The abscess group had significantly more aortic root replacements as well as longer cardiopulmonary bypass and crossclamp times. Operative mortality was 8.4% and 3.8% (P = .11) for the abscess and no abscess groups, respectively. Nevertheless, the root-abscess group had prolonged ventilation and longer intensive care unit stays. Kaplan-Meier survival was similar between root abscess and no abscess groups (10-year survival 41% vs 43%; P = .35). Significant risk factors for all-time mortality included age greater than 70 (hazard ratio [HR], 2.85; 95% confidence interval [CI], 1.55, 5.24), the presence of a root abscess (HR, 1.42; 95% CI, 1.02, 1.96), intravenous drug use (HR, 1.81; 95% CI, 1.13, 2.89), congestive heart failure (HR, 1.72; 95% CI, 1.22, 2.42), renal failure requiring dialysis (HR, 3.26; 95% CI, 2.30, 4.64), liver disease (HR, 3.04; 95% CI, 1.65, 5.60), and postoperative sepsis (HR, 3.00; 95% CI, 1.30, 6.93). The 10-year rate of reoperation was also similar between groups (5.9% vs 7.9%). CONCLUSIONS: Thorough and extensive debridement is critical for successful treatment of active endocarditis with root abscess. Bioprosthetic stented and stentless valves are valid conduits to treat endocarditis with root abscess.
OBJECTIVES: To evaluate the influence of an aortic root abscess on perioperative outcomes and long-term survival in patients with active infectious endocarditis that was treated surgically. METHODS: From 1996 to 2017, 336 consecutive patients were treated with aortic valve or root replacement for infective endocarditis, including patients with (n = 179) or without (n = 157) a root abscess. Data were obtained from the Society of Thoracic Surgeons data warehouse, through chart review, patient surveys, and National Death Index data. RESULTS: Demographic characteristics were similar between groups except the root abscess group had a significantly lower prevalence of congestive heart failure and higher rates of prosthetic valve endocarditis. The abscess group had significantly more aortic root replacements as well as longer cardiopulmonary bypass and crossclamp times. Operative mortality was 8.4% and 3.8% (P = .11) for the abscess and no abscess groups, respectively. Nevertheless, the root-abscess group had prolonged ventilation and longer intensive care unit stays. Kaplan-Meier survival was similar between root abscess and no abscess groups (10-year survival 41% vs 43%; P = .35). Significant risk factors for all-time mortality included age greater than 70 (hazard ratio [HR], 2.85; 95% confidence interval [CI], 1.55, 5.24), the presence of a root abscess (HR, 1.42; 95% CI, 1.02, 1.96), intravenous drug use (HR, 1.81; 95% CI, 1.13, 2.89), congestive heart failure (HR, 1.72; 95% CI, 1.22, 2.42), renal failure requiring dialysis (HR, 3.26; 95% CI, 2.30, 4.64), liver disease (HR, 3.04; 95% CI, 1.65, 5.60), and postoperative sepsis (HR, 3.00; 95% CI, 1.30, 6.93). The 10-year rate of reoperation was also similar between groups (5.9% vs 7.9%). CONCLUSIONS: Thorough and extensive debridement is critical for successful treatment of active endocarditis with root abscess. Bioprosthetic stented and stentless valves are valid conduits to treat endocarditis with root abscess.
Authors: Ignasi Anguera; Jose M Miro; Jose Alberto San Roman; Aristides de Alarcon; Manuel Anguita; Benito Almirante; Artur Evangelista; Christopher H Cabell; Isidre Vilacosta; Tomas Ripoll; Patricia Muñoz; Enrique Navas; Carlos Gonzalez-Juanatey; Cristina Sarria; Ignacio Garcia-Bolao; M Carmen Fariñas; Gabriel Rufi; Francisco Miralles; Carles Pare; Vance G Fowler; Carlos A Mestres; Elisa de Lazzari; Joan R Guma; Ana del Río; G Ralph Corey Journal: Am J Cardiol Date: 2006-09-18 Impact factor: 2.778
Authors: Arminder Singh Jassar; Joseph E Bavaria; Wilson Y Szeto; Patrick J Moeller; Jon Maniaci; Rita K Milewski; Joseph H Gorman; Nimesh D Desai; Robert C Gorman; Alberto Pochettino Journal: Ann Thorac Surg Date: 2011-12-22 Impact factor: 4.330
Authors: Joon Bum Kim; Julius I Ejiofor; Maroun Yammine; Masahiko Ando; Janice M Camuso; Ilan Youngster; Sandra B Nelson; Arthur Y Kim; Serguei I Melnitchouk; James D Rawn; Thomas E MacGillivray; Lawrence H Cohn; John G Byrne; Thoralf M Sundt Journal: J Thorac Cardiovasc Surg Date: 2016-03-12 Impact factor: 5.209
Authors: Tan Le; Nathan J Graham; Aroma Naeem; Jeffrey Clemence; Juan Caceres; Xiaoting Wu; Himanshu J Patel; Karen M Kim; G Michael Deeb; Bo Yang Journal: JTCVS Open Date: 2021-09-15
Authors: Jeffrey Clemence; Juan Caceres; Tom Ren; Xiaoting Wu; Karen M Kim; Himanshu J Patel; G Michael Deeb; Bo Yang Journal: J Thorac Cardiovasc Surg Date: 2020-08-26 Impact factor: 6.439